首页> 美国卫生研究院文献>Digestive Diseases (Basel Switzerland) >Dendritic Cell-T-Cell Circuitry in Health and Changes in Inflammatory Bowel Disease and Its Treatment
【2h】

Dendritic Cell-T-Cell Circuitry in Health and Changes in Inflammatory Bowel Disease and Its Treatment

机译:树突状细胞-T-细胞回路在健康和炎症性肠病中的变化及其治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDendritic, antigen-presenting cells (DCs) determine not only whether lymphocytes produce different types of immune response but also tissue-homing profiles of lymphocytes they stimulate. For example, in health, mucosal DC stimulate T cells focused to home to the mucosa; DC/T-cell circuitry thus targets immune responses to specific tissue locations. Therapies being introduced for inflammatory bowel disease (IBD) include antibodies to gut-homing molecules such as α4β7 (Vedolizumab) used ostensibly to block gut-homing lymphocytes. However, such lymphocytes are dependent on the tissue specificity of DC that stimulated them.
机译:背景技术树突状抗原呈递细胞(DC)不仅决定淋巴细胞是否产生不同类型的免疫应答,而且决定它们刺激的淋巴细胞的组织归巢分布。例如,在健康方面,粘膜DC刺激T细胞集中于粘膜的原位。因此,DC / T细胞电路将免疫反应靶向特定的组织位置。针对炎症性肠病(IBD)引入的疗法包括针对肠归巢分子的抗体,例如表面上用来阻断肠归巢淋巴细胞的α4β7(Vedolizumab)。但是,这种淋巴细胞取决于刺激它们的DC的组织特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号